Impact of Pharmaceutical Prior Authorisation Policies Jaume Puig-JunoyIván Moreno-Torres Review Article 22 September 2012 Pages: 637 - 648
The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis Grant H. Skrepnek Review Article 22 September 2012 Pages: 649 - 664
Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis Roberto Dal NegroPeter PiskorzXavier Badia Original Research Article 22 September 2012 Pages: 665 - 676
Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US Joseph A. PaladinoMartin H. AdelmanPaul B. Iannini Original Research Article 22 September 2012 Pages: 677 - 683
A Stated Preference Binary Choice Experiment to Explore NICE Decision Making Paul TappendenJohn BrazierJames Chilcott Original Research Article 22 September 2012 Pages: 685 - 693
A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease Maureen P. M. H. Rutten-van MölkenFloortje E. van NootenPeter M. A. Calverley Original Research Article 22 September 2012 Pages: 695 - 711